±±Ê¦´óϸ°ûÉúÎïѧ£º M<nKk#!+h
Ò»¡¢ Ãû´Ê½âÊÍ£º F'~\!dNL
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© |n*nByL/
2£® PCR£¨96£© -~Ll;}nZC
3£® ·ºËØ£¨ubquitin£©£¨96£© WQJnWe
4£® °é·Ö×Ó£¨chapron£©£¨96£© -:$#ko
W
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© 9;ZaL7>
6£® DG£IP3£¨96£© pXoD*o b
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© jTeHI|b
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© rEoMj)~\4&
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© _A>?@3La9
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© QWncKE,O$
11£® Transformation£¨92£© tgR4C#a
12£® TransfectionתȾ£¨92£© H;1_"
13£® Transcytosis×ªÒÆ×÷Óã¨92£© uht>@ WSg|
14£® Transductionתµ¼£¨92£© e|-%-juI
15£® Transdetermination£¨92£© #CV;Np
16£® Transdifferentiation£¨92£© j5Cf\*B4J
17£® Transgenic animalת»ùÒò¶¯Î92£© (:9=M5d
18£® Rb£1£¨92£©
` P,-NVB
19£® P53£¨92¡¢91£© S/2lK*F
20£® C£jun£¨92£© +{r~-Rn3
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© w$evAPuz^
22£® °ûÄÚÌ壨99£© @'>Ul!.]
23£® Cyclin dependent kinase inhibitor(CDKI)(99) RSTA!?K/.
24£® G£protein£¨91£© Clo}kdkd_
25£® Restriction point£¨91£© {Qf/.[
26£® Antipost£¨91£© H"; !A=0
27£® Capping£¨91£© f;`7}7C
28£® TATAbox£¨91£© EJid@
29£® cDNA library£¨90£© O'~>AC5{
30£® Aritotic apparatus£¨90£© 8+n*S$
31£® ¿çĤÐźŠtransmembrane signal£¨90£© W%
-`
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© :5#iVa#<
33£® Nuclear lamina£¨90£© 5L 0w!q'W
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£© }nK=~Wcu\
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© aJzyEb
36£® ϸ°û·Ö»¯£¨00£© $lAQcG&Q
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£©
(RBB0CE
38£® ¿Ë¡£¨00£© g/W&Ap;qVL
39£® »ùÒò×飨00£© i$g6C
40£® Caspase£¨00£© <Em|0hth
41£® ת¼Òò×Ó£¨00£© 68()2v4X
42£® ÅßÌ¥¸Éϸ°û£¨01£© 6[3>[ej:x
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© [2.;gZj
44£® DNAоƬ£¨01£© 7Ml OBPh
¶þ¡¢ ÎÊ´ðÌ⣺ [l*;+N+
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© Rebo.6rG
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æä¹¦ÄÜ£¨95£© IWT
-)+
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© j-k]|0ea}
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© We@wN:
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© 'EO"0,
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£©
+wE>h>?;
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© 3RP\w~?
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© ~mvD|$1z
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© >@.:9}Z
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿ØÏ¸°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© t&MLgu
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷ÍÆ¶¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© %TDY &@i=
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© }UWi[UgA
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£© UJ^-T+fut
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© 9D
@}(t!
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹ØÏµ£¨95£© ^o[(F<q
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£© zC WN,K`
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æä¹¦ÄÜ£¨93£© `e}6/~R`
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£© 13MB1n
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© d$PQb9Q+f
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æä¶¨Î»¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© Vb/XT{T;b
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäĿǰËùÖªµÄ¹¦ÄÜ£¨01£© N3&n"w _d
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖØµãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£©
ngl8) B
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© wQrD(Dv(yA
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£© FK,Jk04on
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© otJHcGv
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆÚµÄµ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© #QKgY7
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹ØÏµ£¨91£© f4+}k GJN
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© ($s%B
29£® ÊÔÊöºáÎÆ¼¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© Y@'ahxF
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æä¹¦ÄÜ£¨95£© KZI-/H+
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£© c\N-B,m&
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© z{G@t0q
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£©
oU)HxV
34£® ¾ÙÀý˵Ã÷ÃâÒßÓ«¹âFISH¡¢ÃâÒߵ羵ÖîÏî¼¼ÊõµÄ»ù±¾ÔÀí¼°ÆäÔÚϸ°ûÉúÎïѧÑо¿Öеĸ÷½â¾öʲôÎÊÌ⣨94£© ziG]BZ
35£® ÄãµÄ˶ʿÂÛÎÄÌá³öÁËʲôÎÊÌ⣿ÈçºÎ½â¾öµÄ£¿½áÂÛÊÇʲô£¿£¨96¡¢94¡¢00£©